Psychological aspects of ovarian cancer

Cancer Investigation

Volumn 17, Issue 5, 1999, Pages 335-341

  Hamilton, Andrea B ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; CA 125 ANTIGEN; CLONAZEPAM; DEXAMETHASONE; LORAZEPAM;

ANXIETY; CANCER PAIN; CANCER SURVIVAL; DEPRESSION; FEMALE; FEMININITY; GENETIC COUNSELING; GENETIC RISK; GROUP THERAPY; HUMAN; MENTAL STRESS; ONCOGENE; OVARY CANCER; PATIENT INFORMATION; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RECURRENCE RISK; REVIEW;

EID: 0033035091     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357909909032875     Document Type: Review

References (39)

1. American Cancer Society: Cancer Facts and Figures 1997. Atlanta: American Cancer Society, 1997.
2. Averette HE, Janicek MF, Menck HR: The national cancer data base report on ovarian cancer. Cancer 76:1096-1102, 1995.
3. Easton DF, Ford D, Bishop DT, the Breast Cancer Linkage Consortium: Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am J Human Genet 56:265-271, 1995.
4. Westoff C: Ovarian cancer. Annu Rev Public Health 17:85-96, 1996.
5. Ford D, Easton DF, Bishop DT, et al: Risks of cancer in BRCA1 mutation carriers. Lancet 343:692-695, 1994.
6. Burke W, Daly M, Garber J, et al: Recommendations for follow-up care of individuals with an inherited predisposition to cancer II. BRCA1 and BRCA2. JAMA 277:997-1003, 1997.
7. Bourne TH, Campbell S, Reynolds KM, et al: Screening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging. Br Med J 306:1025-1029, 1993.
8. Kramer BS, Gohagan J, Prorok PC, et al: A National Cancer Institute-sponsored screening trial for prostatic, lung, colorectal, and ovarian cancers. Cancer 71:589-593, 1993.
9. Robinson GE, Rosen BP, Bradley LN, et al: Psychological impact of screening for familial ovarian cancer: reactions to initial assessment. Gynecol Oncol 65:197-205, 1997.
10. Blazer DG, Kessler RC, McGonagle KA, et al: The prevalence and distribution of major depression in a natural community sample: the National Comorbidity Survey. Am J Psychiatry 151:979-986, 1994.
11. Wardel J: Women at risk of ovarian cancer. J Natl Cancer Inst Monogr 17:81-85, 1995.
12. Aylard PR, Gooding JH, McKenna PJ, et al: A validation study of three anxiety and depression self-assessment scales. J Psychosom Res 31:261-268, 1987.
13. Zigmond AS, Snaith RP: The Hospital Anxiety and Depression Scale. Acta Psych Scand 67:361-370, 1983.
14. Weisman AD, Worden JW: The existential plight in cancer: significance of the first 100 days. Int J Psych Med 7:1-15, 1976.
15. Weisman AD: A model for psychosocial phasing in cancer. Gen Hosp Psych 3:187-195, 1979.
16. Cain EN, Kohorn El, Quinlan DM, et al: Psychosocial benefits of a cancer support group. Cancer 57:183-189, 1986.
17. Capone MA, Good RS, Westie KS, et al: Psychosocial rehabilitation of gynecologic oncology patients. Arch Phys Med Rehabil 61:128-132, 1980.
18. Holland JC: Clinical course of cancer. In: The Handbook of Psychooncology: Psychological Care of the Patient with Cancer, edited by JC Holland, JH Rowland, New York, Oxford University Press, 1989, pp. 75-100.
19. Sardell AN, Trierweiler SJ: Disclosing the cancer diagnosis. Cancer 72:3355-3365, 1993.
20. Massie MJ, Shakin MD: Management of depression and anxiety in cancer patients. In: Psychiatric Aspects of Symptom Management in Cancer Patients, edited by W Breitbart, JC Holland, Washington, DC, American Psychiatric Press, Inc., 7993, pp. 1-21.
21. Waxler-Morrison N, Hislop TG, Mears B, et al: Effects of social relationships on survival for women with breast cancer: a prospective study. Soc Sci Med 33:177-183, 1991.
22. Kornblith AB, Thaler HT, Wong G, et al: Quality of life of women with ovarian cancer. Gynecol Oncol 59: 231-242, 1995.
23. Portenoy RK, Kornblith AB, Wong G, et al: Pain in ovarian cancer patients: prevalence, characteristics, and associated symptoms. Cancer 74:907-915, 1994.
24. Guidozzi F: Living with ovarian cancer. Gynecol Oncol 50:202-207, 1993.
25. Lancee WJ, Vachon MLS, Ghadirian P, et al: The impact of pain and impaired role performance on distress in persons with cancer. Can J Psych 39:617-622, 1994.
26. Agency for Health Care Policy and Research: Management of Cancer Pain, Washington, DC, U.S. Department of Health and Human Services, 1994.
27. Pearce J, Hawton K, Blake F: Psychological and sexual symptoms associated with the menopause and the effects of hormone replacement therapy. Br J Psych 167:163-173, 1995.
28. Zweifel JE, O'Brein WH: A meta-analysis of the effect of hormone replacement therapy upon depressed mood. Psychoneuroendocrinology 22:189-212, 1997.
29. Schneider LS, Small GW, Hamilton SH, et al: Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Am J Geriatr Psych 5:97-106, 1997.
30. Wolkowitz OM: Prospective controlled studies of the behavioral and biological effects of exogenous corticosteroids. Psychoneuroendocrinology 19:233-255, 1994.
31. Gleishman SB, Lesko LM, Breitbart W: Treatment of organic mental disorders in cancer patients. In: Psychiatric Aspects of Symptom Management in Cancer Patients, edited by W Breitbart, JC Holland, Washington, DC, American Psychiatric Press, Inc., 1993, pp. 23-47.
32. Andersen BL, Anderson B, deProsse C: Controlled prospective longitudinal study of women with cancer. II. Psychological outcomes. J Consult Clin Psychol 57:692-697, 1989.
33. Roberts CS, Rosetti K, Cone D, et al: Psychosocial impact of gynecologic cancer: a descriptive study. J Psychosoc Oncol 10:99-109, 1992.
34. Ersek M, Ferrell BR, Dow KH, et al: Quality of life in women with ovarian cancer. West J Nurs Res 19:334-250, 1997.
35. Auchincloss SS: After treatment: psychosocial issues in gynecologic cancer survivorship. Cancer 76(Suppl):2117-2124, 1995.
36. Anderson B, Lutgendorf S: Quality of life in gynecologic cancer survivors. CA Cancer J Clin 47:218-225, 1997.
37. Andersen BL, Anderson B, deProsse C: Controlled prospective longitudinal study of women with cancer. I. Sexual functioning outcomes. J Consult Clin Psychol 57:683-691, 1989.
38. Andersen BL: Quality of life for women with gynecologic cancer. Curr Opin Obstet Gynecol 7:69-76, 1995.
39. Weisman AD, Worden JW: The emotional impact of recurrent cancer. J Psychosoc Oncol 3:5-16, 1986.